Jade Biosciences (JBIO) Current Assets (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Current Assets data on file, last reported at $318.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 311.66% year-over-year to $318.5 million; the trailing twelve-month figure through Mar 2026 stood at $318.5 million (up 311.66% YoY), and the FY2025 full-year result was $348.8 million, up 400.78% from the prior year.
• Current Assets for Q1 2026 stood at $318.5 million, down from $348.8 million in the prior quarter.
• Across five years, Current Assets topped out at $348.8 million in Q4 2025 and bottomed at $69.7 million in Q4 2024.
• The 5-year median for Current Assets is $137.6 million (2023), against an average of $157.3 million.
• The widest annual swing landed in 2024, when Current Assets plunged 43.93%; it then soared 400.78% in 2025.
• A 5-year view of Current Assets shows it stood at $131.5 million in 2022, then decreased by 5.52% to $124.2 million in 2023, then slumped by 43.93% to $69.7 million in 2024, then jumped by 400.78% to $348.8 million in 2025, then declined by 8.69% to $318.5 million in 2026.
• The last three Current Assets figures came in at $318.5 million (Q1 2026), $348.8 million (Q4 2025), and $201.4 million (Q3 2025), per Business Quant data.

Peer Comparison